GlassScriptPhysician profile
Kenneth Neil Dippel
NPI 1073662664
$377.00
in general payments reported to CMS, 2019-2025
7 companies · $35.37 in 2025
The $35.37 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $30.96 · 2022: $24.64 · 2023: $17.70 · 2024: $268 · 2025: $35.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $321.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $321.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $170.99 | 2024 | Torus Stent Graft System, Endocross Device, Afx2 Bifurcated Endograft System |
| Silk Road Medical, INC. | $76.02 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Smith+Nephew, INC. | $54.12 | 2021-2023 | Regranex, Collagenase Santyl |
| Janssen Pharmaceuticals, INC | $21.32 | 2024 | Xarelto |
| Bard Peripheral Vascular, INC. | $19.18 | 2021 | |
| Bolton Medical INC | $18.11 | 2025 | Treo Abdominal Stent-Graft System |
| Becton, Dickinson and Company | $17.26 | 2025 | Venovo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Dippel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.